Considering the antimicrobial sensitivity of the intestinal botulism agent Clostridium butyricum when treating concomitant infections.
In Italy, neurotoxigenic Clostridium butyricum has been reported as a new agent of intestinal toxemia botulism, and most of the cases have been associated with enterocolitis. Although infections concomitant with botulism must be treated with antibiotics, this can increase the severity of botulism. We discuss the sensitivity of this agent to certain antibiotics, compared to findings on the sensitivity of C. botulinum.
Fenicia
Lucia
L
National Reference Center for Botulism, Food Laboratory, Istituto Superiore di Sanità, Rome, Italy.
Ferrini
Anna Maria
AM
Anniballi
Fabrizio
F
Mannoni
Veruscka
V
Aureli
Paolo
P
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001906:Botulism / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D003014:Clostridium botulinum; D004351:Drug Resistance; D006801:Humans; D007558:Italy; D014115:Toxemia
D000900:Anti-Bacterial Agents